H. Nakanishi

发表

Impact of immune‐related adverse events in patients with hepatocellular carcinoma treated with atezolizumab plus bevacizumab

N. Izumi, R. Okamoto, C. Maeyashiki, 2024, Journal of gastroenterology and hepatology.

Two Cases of Immune-Related ACTH Deficiency after the Initiation of Atezolizumab plus Bevacizumab for Multiple Hepatocellular Carcinoma

C. Maeyashiki, N. Tamaki, K. Tsuchiya, 2023, Annals of Case Reports.